Jiangbo Pharmaceuticals Announces New Ticker (JGBO)... ( LAIYANG China May 11 Asia-FirstCa...)

Jiangbo Pharmaceuticals Announces New Ticker (JGBO) and CUSIP

Date:5/11/2009

LAIYANG, China, May 11 /PRNewswire-Asia-FirstCall/ -- Jiangbo Pharmaceuticals, Inc. (OTC Bulletin Board: GNPH) (the "Company"), a U.S. pharmaceutical company with its principal operations in the People's Republic of China, today announced that its stock will start trading on the Over the Counter Bulletin Board under the new ticker symbol "JGBO" as of May 12, 2009. The Company's shares will cease trading under the ticker symbol "GNPH" at the end of May 11, 2009.

The Company's shares will be identified under a new CUSIP: 47737 R 10 1.

About Jiangbo Pharmaceuticals, Inc.

Jiangbo Pharmaceuticals, Inc. is a U.S. public company engaged in the research, development, production, marketing and sales of pharmaceutical products in the People's Republic of China. Its operations are located in Eastern China in an Economic Development Zone in Laiyang City, Shandong province. Jiangbo is a major pharmaceutical company in China producing both western and Chinese herbal-based medical drugs in tablet, capsule, granule, syrup and electuary (sticky syrup) form. http://www.jiangbopharma.com

Safe Harbor Statement

Certain statements in this press release that are not historical facts are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are not guarantees of future performance and are subject to risks and uncertainties that could cause the Company's actual results and financial position to differ materially from those included within the forward-looking statements. Forward-looking statements involve risks and uncertainties. Actual results may differ materially from anticipated or predicted results, and reported results should not be considered as an indication of future performance. The potential risks and uncertainties include, among others, the Company's abi
'/>"/>

SOURCE Jiangbo Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related medicine news :

1. Genesis Pharmaceuticals Changes its Name to Jiangbo Pharmaceuticals, Inc. to Reflect its Brand Name
2. Vanda Pharmaceuticals Announces Withdrawal of Director Nominees and Proposal to Liquidate Submitted by Tang Capital
3. Jazz Pharmaceuticals, Inc. Announces First Quarter 2009 Financial Results
4. Photos: Generic Pharmaceuticals Saved $734 Billion over Last Decade
5. VIA Pharmaceuticals Announces Positive Phase 2 Results of VIA-2291 in Cardiovascular Patients Using Serial MDCT Imaging of Coronary Plaque
6. Valeant Pharmaceuticals to Present at Bank of America and Merrill Lynch 2009 Health Care Conference
7. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss First Quarter 2009 Financial Results on May 7, 2009
8. Watson Pharmaceuticals Reports First Quarter 2009 Results; Raises 2009 Outlook
9. Conference Call Advisory - NUCRYST Pharmaceuticals Corp. Conference Call to Discuss 2009 First Quarter Results
10. Endo Pharmaceuticals Reports First Quarter 2009 Financial Results
11. Ferring Pharmaceuticals and RESOLVE: The National Infertility Association Join Together to Launch Nurse Liaison Program

Post Your Comments:

(Date:5/21/2013)... Interactive, one of the city's leading online marketing and ... year – and announced another milestone this week as ... Kids II, a designer of innovative baby toys and ... specializing in search engine optimization (SEO) or the art ... company now offers a host of boutique online marketing ...

(Date:5/21/2013)... May 21, 2013 Tools4ever, the market ... made its Self Service Reset Password Management (SSRPM) suitable ... can now use the service on mobile systems i.e.; ... users can easily reset their Windows passwords anywhere, anytime. ... questions correctly, the user may then reset his or ...

(Date:5/21/2013)... -- Racial disparities exist in the treatment of non-small ... according to a large new study. Although most ... their initial treatment, researchers found that blacks were less ... the early stages of the disease. Hispanics were more ... 2 disease than white patients. "In our study ...

(Date:5/21/2013)... ATS 2013, PHILADELPHIA─Treatment with an Alpha-1 proteinase inhibitor ... tissue from breakdown and protects the lung,s elasticity, ... in patients with Alpha-1 antitrypsin deficiency (AATD), a ... presented at the 2013 American Thoracic Society International ... A1-PIin preventing the loss of lung tissue as ...

(Date:5/21/2013)... (PRWEB) May 21, 2013 As ... on marketing, sales and service program investments, the ... dramatic growth and enhanced offerings including Data Analytics ... as Gamification features, reports premier CRM consulting firm ... annual Top 15 CRM Software Awards. Since 1990, ...

Breaking Medicine News(10 mins):Health News:Everspark Named Interactive Marketing Company for Kids II 2 Health News:Tools4ever’s password reset software ready for BYOD 2 Health News:Racial Disparities Seen in U.S. Lung Cancer Treatment 2 Health News:Treatment with A1-PI slows the progression of emphysema in Alpha-1 antitrypsin deficiency 2 Health News:Treatment with A1-PI slows the progression of emphysema in Alpha-1 antitrypsin deficiency 3 Health News:ISM Announces Winners of 2013 Top 15 CRM Software Awards for both ‘Enterprise’ and ‘Small & Medium Business’ Solutions 2 Health News:ISM Announces Winners of 2013 Top 15 CRM Software Awards for both ‘Enterprise’ and ‘Small & Medium Business’ Solutions 3 Health News:ISM Announces Winners of 2013 Top 15 CRM Software Awards for both ‘Enterprise’ and ‘Small & Medium Business’ Solutions 4 Health News:ISM Announces Winners of 2013 Top 15 CRM Software Awards for both ‘Enterprise’ and ‘Small & Medium Business’ Solutions 5

[0] Everspark Named Interactive Marketing Company for Kids II [0] Tools4ever’s password reset software ready for BYOD [0] Racial Disparities Seen in U.S. Lung Cancer Treatment [0] Treatment with A1-PI slows the progression of emphysema in Alpha-1 antitrypsin deficiency [0] ISM Announces Winners of 2013 Top 15 CRM Software Awards for both ‘Enterprise’ and ‘Small & Medium Business’ Solutions

... Nov. 30 Caraco Pharmaceutical,Laboratories, Ltd., (Amex: ... and Drug,Administration (FDA) has granted tentative approval for ... Oxalate Tablets,(escitalopram), 5 mg, 10 mg, and 20 ... of major depressive,disorder. This tentative approval is for ...

... Nov. 30 ChemDiv, Inc. and Orion ... as a discovery partner in small,molecule therapeutics ... terms of the agreement, ChemDiv will deploy ... including the world,s,largest commercially available chemical library, ...

... MMS - A Medical Supply,Company announced their renewal ... The contract naming MMS as the primary supplier ... an additional four,years, through December, 2011. It is ... is a consortium of four leading,independent Long Island ...

... evidence that supplementation during pregnancy makes little difference , , ... of vitamins E and C doesn,t reduce the chances ... are at risk for the dangerous pregnancy complication, a ... doubt on the effectiveness of this regimen in preventing ...

... Nov. 30 Today, Test for Life,marked the 19th annual ... challenge here in the U.S. and all Americans should know ... prevention efforts,have saved thousands of lives, but many of our ... Day, UNAIDS and the World Health Organization,issued a report that ...

... those living with food allergies, WHITE PLAINS, N.Y., ... from food allergies. For most, it means avoiding,certain foods ... even fatal,reactions., Now those with food allergies can ... re-positional Post-It(R) notes that help,alert others to an allergy ...

Cached Medicine News:Health News:Caraco Pharmaceutical Laboratories, Ltd. Announces Tentative FDA Approval for Generic Lexapro(R) 2 Health News:Orion Pharma Selects ChemDiv as A Partner in Drug Discovery Services 2 Health News:Announcing Prime Vendor Contract with LIHPA 2 Health News:Extra Doses of Vitamins C, E Don't Guard Against Preeclampsia 2 Health News:Extra Doses of Vitamins C, E Don't Guard Against Preeclampsia 3 Health News:Test for Life Marks World AIDS Day, Heightens Awareness of HIV/AIDS Testing in the U.S. 2 Health News:AllerNotes Help Take Food Allergies Off the Table 2

Caraco Pharmaceutical Laboratories, Ltd. Announces Tentative FDA Approval for Generic Lexapro(R)Orion Pharma Selects ChemDiv as A Partner in Drug Discovery Services Announcing Prime Vendor Contract with LIHPA Extra Doses of Vitamins C, E Don't Guard Against Preeclampsia Test for Life Marks World AIDS Day, Heightens Awareness of HIV/AIDS Testing in the U.S.AllerNotes Help Take Food Allergies Off the Table

(Date:5/21/2013)... VIEW, Calif. , May 21, 2013 /PRNewswire/ ... design and manufacture of wireless personal healthcare products ... broaden its reach, announcing the release of two ... wireless blood pressure monitors and scales: the Wireless ... (Photo: http://photos.prnewswire.com/prnh/20130521/SF17618 ) ...

(Date:5/21/2013)... N.Y. , May 21, 2013 The North ... system used to measure hand-washing compliance at North Shore ... by introducing cameras in operating rooms at ... http://photos.prnewswire.com/prnh/20130521/NY17810 ) The new pilot program ... in their operating rooms (ORs), the first time in ...

(Date:5/21/2013)... 21, 2013 BioElectronics Corp. (PINKSHEETS: BIEL), ... devices, announced that CEO, Andrew J. ... FDA,s Medical Advisory Committee, Orthopedic and Rehabilitation Panel ... over the counter sales. "It,s been ... device classification schema," Whelan said. "While the old ...

Breaking Medicine Technology:iHealth Lab adds new products and partners to mobile personal healthcare offering 2 iHealth Lab adds new products and partners to mobile personal healthcare offering 3 North Shore-LIJ Extends Use of 3rd Party Remote Video Auditing into ORs 2 North Shore-LIJ Extends Use of 3rd Party Remote Video Auditing into ORs 3 North Shore-LIJ Extends Use of 3rd Party Remote Video Auditing into ORs 4 BioElectronics Presents FDA Reclassification Panel 2 BioElectronics Presents FDA Reclassification Panel 3

[0] iHealth Lab adds new products and partners to mobile personal healthcare offering [0] North Shore-LIJ Extends Use of 3rd Party Remote Video Auditing into ORs [0] BioElectronics Presents FDA Reclassification Panel

... ,, NEW YORK , May 12 Reportlinker.com announces that a new market ... , Antifungal Drugs: Technologies and ... http://www.reportlinker.com/p0196570/Antifungal-Drugs-Technologies-and-Global-Markets.html , ... , , , ...

... 11 Stereotaxis, Inc. (Nasdaq: STXS ) today announces the ... Navigation platform that facilitates remote manipulation of diagnostic devices used during electrophysiology ... at the HRS meeting this week, and will be commercially available when ... , , ...

Reportlinker Adds Antifungal Drugs: Technologies and Global Markets Stereotaxis Announces Vdrive(TM), a New Technology for Remote Navigation of Diagnostic Devices

Inquire...

...

VACUETTE Trace Element tubes - Ridged (safety screw cap) are designed to test trace elements such as Cu, Zn, Pb, etc....

Inquire...

Medicine Products:

MONOJECT Royal Blue Stopper (No Additive)MONOJECT Royal Blue Stopper (Powdered Additive)VACUETTE Trace Element tubes - Ridged (safety screw cap)MONOJECT Red Stopper (Silicone Coated Tube)